• Exchange: NASDAQ GS
  • Sector: Health Care
  • Industry: Biotech & Pharma
  • Sub-Industry: Specialty Pharma

Portola Pharmaceuticals Inc

+ Add to Watchlist

PTLA:US

29.0200 USD 1.6900 5.50%

As of 20:10:00 ET on 12/22/2014.

Snapshot for Portola Pharmaceuticals Inc (PTLA)

Open: 30.3100 Day's Range: 28.7500 - 30.9900 Volume: 415,898
Previous Close: 30.7100 52wk Range: 19.5900 - 31.4800 1-Yr Rtn: +22.97%

Stock Chart for PTLA

No chart data available.
  • PTLA:US 29.0200
  • 1D
  • 1M
  • 1Y
30.7100
Interactive PTLA Chart

Previous Close

No chart data available.
Interactive Chart
  • 1D
  • 1W
  • 1M
  • YTD
  • 1Y
  • 3Y
  • 5Y
Close:
Open:
High:
Low:
Volume:
Recently Viewed Symbols
Save as Watchlist
Saving as watchlist...

Key Statistics for PTLA

Current P/E Ratio (ttm) -
Estimated P/E(12/2014) -
Relative P/E vs. SPX -
Earnings Per Share (USD) (ttm) -3.0046
Est. EPS (USD) (12/2014) -3.2740
Est. PEG Ratio -
Market Cap (M USD) 1,411.31
Shares Outstanding (M) 48.63
30 Day Average Volume 360,468
Price/Book (mrq) 5.7562
Price/Sale (ttm) 127.7523
Dividend Indicated Gross Yield -%
Cash Dividend -
Dividend Ex-Date
5 Year Dividend Growth -
Next Earnings Announcement 02/27/2015
mrq = Most Recent Quarter; ttm = Trailing Twelve Months

Income Statement for PTLA

  • Revenue
  • Net Income (M/USD)
  • Profit Margin (%)

Company Profile & Key Executives for PTLA

Portola Pharmaceuticals, Inc. provides specialty pharmaceutical products. The Company offers novel therapeutics for thrombosis, hematologic disorders, and inflammation. Portola Pharmaceuticals serves customers in the United States.

Charles J HomcyCo-Chairman/Co-FounderHollings C RentonCo-Chairman
William LisChief Executive OfficerMardi C DierExec VP/CFO
More Company Profile & Key Executives for PTLA

Quotes delayed, except where indicated otherwise. All prices in local currency. Time is ET.

Sponsored Link
Advertisement
Advertisement
Sponsored Links
Advertisements
sec ||= nil